The natural history of nonalcoholic fatty liver disease: a population-based cohort study
- PMID: 16012941
- DOI: 10.1053/j.gastro.2005.04.014
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
Abstract
Background & aims: The natural history of nonalcoholic fatty liver disease (NAFLD) in the community remains unknown. We sought to determine survival and liver-related morbidity among community-based NAFLD patients.
Methods: Four hundred twenty patients diagnosed with NAFLD in Olmsted County, Minnesota, between 1980 and 2000 were identified using the resources of the Rochester Epidemiology Project. Medical records were reviewed to confirm diagnosis and determine outcomes up to 2003. Overall survival was compared with the general Minnesota population of the same age and sex.
Results: Mean (SD) age at diagnosis was 49 (15) years; 231 (49%) were male. Mean follow-up was 7.6 (4.0) years (range, 0.1-23.5) culminating in 3192 person-years follow-up. Overall, 53 of 420 (12.6%) patients died. Survival was lower than the expected survival for the general population (standardized mortality ratio, 1.34; 95% CI, 1.003-1.76; P = .03). Higher mortality was associated with age (hazard ratio per decade, 2.2; 95% CI, 1.7-2.7), impaired fasting glucose (hazard ratio, 2.6; 95% CI, 1.3-5.2), and cirrhosis (hazard ratio, 3.1, 95% CI, 1.2-7.8). Liver disease was the third leading cause of death (as compared with the thirteenth leading cause of death in the general Minnesota population), occurring in 7 (1.7%) subjects. Twenty-one (5%) patients were diagnosed with cirrhosis, and 13 (3.1%) developed liver-related complications, including 1 requiring transplantation and 2 developing hepatocellular carcinoma.
Conclusions: Mortality among community-diagnosed NAFLD patients is higher than the general population and is associated with older age, impaired fasting glucose, and cirrhosis. Liver-related death is a leading cause of mortality, although the absolute risk is low.
Comment in
-
Natural history of NAFLD: remarkably benign in the absence of cirrhosis.Gastroenterology. 2005 Jul;129(1):375-8. doi: 10.1053/j.gastro.2005.05.041. Gastroenterology. 2005. PMID: 16012969 Review. No abstract available.
-
The natural history of NAFLD: impressively unimpressive.Gastroenterology. 2005 Nov;129(5):1805. doi: 10.1053/j.gastro.2005.09.041. Gastroenterology. 2005. PMID: 16285987 No abstract available.
-
Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for nonalcoholic fatty liver disease.ACP J Club. 2006 Jan-Feb;144(1):22. ACP J Club. 2006. PMID: 16388571 No abstract available.
-
Are we overestimating the risks of NASH?Gastroenterology. 2006 Mar;130(3):1015-6; author reply 1016-7. doi: 10.1053/j.gastro.2006.01.078. Gastroenterology. 2006. PMID: 16530550 No abstract available.
-
Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for non-alcoholic fatty liver disease.Evid Based Med. 2006 Feb;11(1):26. doi: 10.1136/ebm.11.1.26. Evid Based Med. 2006. PMID: 17213068 No abstract available.
Similar articles
-
Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.Am J Gastroenterol. 2010 Jul;105(7):1567-73. doi: 10.1038/ajg.2010.18. Epub 2010 Feb 9. Am J Gastroenterol. 2010. PMID: 20145609 Free PMC article.
-
NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.World J Gastroenterol. 2013 Feb 28;19(8):1219-29. doi: 10.3748/wjg.v19.i8.1219. World J Gastroenterol. 2013. PMID: 23482703 Free PMC article.
-
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.Hepatology. 2011 Oct;54(4):1208-16. doi: 10.1002/hep.24491. Epub 2011 Aug 9. Hepatology. 2011. PMID: 21688282 Free PMC article.
-
Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.Semin Liver Dis. 2008 Nov;28(4):380-5. doi: 10.1055/s-0028-1091982. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956294 Review.
-
Nonalcoholic fatty liver disease: a systematic review.JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. JAMA. 2015. PMID: 26057287 Review.
Cited by
-
Inhibition of apoptosis in the management of nonalcoholic fatty liver disease.World J Gastrointest Pharmacol Ther. 2013 Feb 6;4(1):4-8. doi: 10.4292/wjgpt.v4.i1.4. World J Gastrointest Pharmacol Ther. 2013. PMID: 23516172 Free PMC article.
-
Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.World J Gastroenterol. 2015 Jan 28;21(4):1189-96. doi: 10.3748/wjg.v21.i4.1189. World J Gastroenterol. 2015. PMID: 25632192 Free PMC article.
-
Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents.Lipids Health Dis. 2015 May 1;14:39. doi: 10.1186/s12944-015-0038-x. Lipids Health Dis. 2015. PMID: 25925168 Free PMC article.
-
Hepatic TLR4 signaling in obese NAFLD.Am J Physiol Gastrointest Liver Physiol. 2015 Aug 15;309(4):G270-8. doi: 10.1152/ajpgi.00304.2014. Epub 2015 Jun 25. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 26113297 Free PMC article.
-
Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma.Exp Mol Med. 2020 Aug;52(8):1209-1219. doi: 10.1038/s12276-020-0480-3. Epub 2020 Aug 7. Exp Mol Med. 2020. PMID: 32770081 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources